{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T13:54:23Z","timestamp":1780149263128,"version":"3.54.0"},"reference-count":80,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Endocrinology & Metabolism"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.tem.2023.09.002","type":"journal-article","created":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T08:13:50Z","timestamp":1695629630000},"page":"838-848","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["N6-methyladenosine RNA modification in nonalcoholic fatty liver disease"],"prefix":"10.1016","volume":"34","author":[{"given":"Ping","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiancheng","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinghua","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tem.2023.09.002_bb0005","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.tem.2023.09.002_bb0010","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/hep.31173","article-title":"Changes in the global burden of chronic liver diseases from 2012 to 2017: the growing impact of NAFLD","volume":"72","author":"Paik","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.tem.2023.09.002_bb0015","doi-asserted-by":"crossref","first-page":"774","DOI":"10.3390\/ijms17050774","article-title":"The natural course of non-alcoholic fatty liver disease","volume":"17","author":"Calzadilla Bertot","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tem.2023.09.002_bb0020","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/8822859","article-title":"Noncoding RNAs in nonalcoholic fatty liver disease: potential diagnosis and prognosis biomarkers","volume":"2020","author":"Khalifa","year":"2020","journal-title":"Dis. Markers"},{"key":"10.1016\/j.tem.2023.09.002_bb0025","article-title":"Complications, morbidity and mortality of nonalcoholic fatty liver disease","volume":"111S","author":"Mantovani","year":"2020","journal-title":"Metabolism"},{"key":"10.1016\/j.tem.2023.09.002_bb0030","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/s41467-023-35804-w","article-title":"The transcription factor ATF3 switches cell death from apoptosis to necroptosis in hepatic steatosis in male mice","volume":"14","author":"Inaba","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tem.2023.09.002_bb0035","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.omto.2021.05.003","article-title":"Regulatory role and mechanism of m6A RNA modification in human metabolic diseases","volume":"22","author":"Zhang","year":"2021","journal-title":"Mol. Ther. Oncolytics"},{"key":"10.1016\/j.tem.2023.09.002_bb0040","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41576-020-00295-8","article-title":"The epitranscriptome beyond m6A","volume":"22","author":"Wiener","year":"2021","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.tem.2023.09.002_bb0045","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0092-8674(75)90158-0","article-title":"Methylated nucleotides block 5\u2032 terminus of HeLa cell messenger RNA","volume":"4","author":"Wei","year":"1975","journal-title":"Cell"},{"key":"10.1016\/j.tem.2023.09.002_bb0050","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0092-8674(74)90131-7","article-title":"Sequences containing methylated nucleotides at the 5\u2032 termini of messenger RNAs: possible implications for processing","volume":"3","author":"Rottman","year":"1974","journal-title":"Cell"},{"key":"10.1016\/j.tem.2023.09.002_bb0055","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12943-020-01207-4","article-title":"Interaction between N6-methyladenosine (m6A) modification and noncoding RNAs in cancer","volume":"19","author":"Chen","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.tem.2023.09.002_bb0060","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/j.cell.2012.05.003","article-title":"Comprehensive analysis of mRNA methylation reveals enrichment in 3\u2032 UTRs and near stop codons","volume":"149","author":"Meyer","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.tem.2023.09.002_bb0065","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/s41576-019-0106-6","article-title":"Regulation of transposable elements by DNA modifications","volume":"20","author":"Deniz","year":"2019","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.tem.2023.09.002_bb0070","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/s41419-021-03585-z","article-title":"Emerging role of RNA modification N6-methyladenosine in immune evasion","volume":"12","author":"Lou","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.tem.2023.09.002_bb0075","article-title":"Effects of writers, erasers and readers within miRNA-related m6A modification in cancers","volume":"2022","author":"Feng","year":"2022","journal-title":"Cell Prolif."},{"key":"10.1016\/j.tem.2023.09.002_bb0080","doi-asserted-by":"crossref","first-page":"W548","DOI":"10.1093\/nar\/gkz479","article-title":"RNAmod: an integrated system for the annotation of mRNA modifications","volume":"47","author":"Liu","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.tem.2023.09.002_bb0085","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.gendis.2021.01.005","article-title":"36 Critical roles of FTO-mediated mRNA m6A demethylation in regulating adipogenesis and lipid metabolism: implications in lipid metabolic disorders","volume":"9","author":"Yang","year":"2022","journal-title":"Genes Dis."},{"key":"10.1016\/j.tem.2023.09.002_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2023.188873","article-title":"N6-methyladenosine RNA modification in PD-1\/PD-L1: novel implications for immunotherapy","volume":"1878","author":"Luo","year":"2023","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.tem.2023.09.002_bb0095","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1080\/15592294.2020.1827722","article-title":"The m6A epitranscriptome opens a new charter in immune system logic","volume":"16","author":"Ma","year":"2021","journal-title":"Epigenetics"},{"key":"10.1016\/j.tem.2023.09.002_bb0100","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41392-020-00450-x","article-title":"The role of m6A modification in the biological functions and diseases","volume":"6","author":"Jiang","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.tem.2023.09.002_bb0105","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12943-020-01204-7","article-title":"The potential role of RNA N6-methyladenosine in cancer progression","volume":"19","author":"Wang","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.tem.2023.09.002_bb0110","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s12943-022-01634-5","article-title":"The role, mechanism, and application of RNA methyltransferase METTL14 in gastrointestinal cancer","volume":"21","author":"Shi","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.tem.2023.09.002_bb0115","doi-asserted-by":"crossref","first-page":"5150","DOI":"10.1016\/j.csbj.2022.09.017","article-title":"Targeting N6-methyladenosine RNA modification combined with immune checkpoint inhibitors: a new approach for cancer therapy","volume":"20","author":"Liu","year":"2022","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.tem.2023.09.002_bb0120","first-page":"785","article-title":"Abnormal m6A modification in non-alcoholic fatty liver disease","volume":"46","author":"Li","year":"2021","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"key":"10.1016\/j.tem.2023.09.002_bb0125","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.780617","article-title":"Analysis of N6-methyladenosine methylation modification in fructose-induced non-alcoholic fatty liver disease","volume":"12","author":"Luo","year":"2021","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.tem.2023.09.002_bb0130","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.2217\/epi-2019-0009","article-title":"Comprehensive analysis of differences of N6-methyladenosine RNA methylomes between high-fat-fed and normal mouse livers","volume":"11","author":"Luo","year":"2019","journal-title":"Epigenomics"},{"key":"10.1016\/j.tem.2023.09.002_bb0135","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.973116","article-title":"New roles of N6-methyladenosine methylation system regulating the occurrence of non-alcoholic fatty liver disease with N6-methyladenosine-modified MYC","volume":"13","author":"Cheng","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.tem.2023.09.002_bb0140","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s12935-021-01799-x","article-title":"The role of IGF2BP2, an m6A reader gene, in human metabolic diseases and cancers","volume":"21","author":"Wang","year":"2021","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.tem.2023.09.002_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.101092","article-title":"Dysregulated lipid metabolism links NAFLD to cardiovascular disease","volume":"42","author":"Deprince","year":"2020","journal-title":"Mol. Metab."},{"key":"10.1016\/j.tem.2023.09.002_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101238","article-title":"Metabolic-associated fatty liver disease and lipoprotein metabolism","volume":"50","author":"Heeren","year":"2021","journal-title":"Mol. Metab."},{"key":"10.1016\/j.tem.2023.09.002_bb0155","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1210\/er.2019-00034","article-title":"The liver as an endocrine organ-linking NAFLD and insulin resistance","volume":"40","author":"Watt","year":"2019","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.tem.2023.09.002_bb0160","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.jhep.2023.02.033","article-title":"Role of immune responses for development of NAFLD-associated liver cancer and prospects for therapeutic modulation","volume":"79","author":"Yahoo","year":"2023","journal-title":"J. Hepatol."},{"key":"10.1016\/j.tem.2023.09.002_bb0165","doi-asserted-by":"crossref","first-page":"271","DOI":"10.7150\/ijbs.50003","article-title":"The emerging roles of m6A modification in liver carcinogenesis","volume":"17","author":"Pan","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.tem.2023.09.002_bb0170","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/s42255-021-00427-2","article-title":"Transcriptional regulation of N6-methyladenosine orchestrates sex-dimorphic metabolic traits","volume":"3","author":"Salisbury","year":"2021","journal-title":"Nat. Metab."},{"key":"10.1016\/j.tem.2023.09.002_bb0175","doi-asserted-by":"crossref","first-page":"5676","DOI":"10.1002\/jcb.26746","article-title":"FTO reduces mitochondria and promotes hepatic fat accumulation through RNA demethylation","volume":"119","author":"Kang","year":"2018","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.tem.2023.09.002_bb0180","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1016\/j.celrep.2018.10.068","article-title":"Circadian clock regulation of hepatic lipid metabolism by modulation of m6A mRNA methylation","volume":"25","author":"Zhong","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.tem.2023.09.002_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114766","article-title":"m6A modification impacts hepatic drug and lipid metabolism properties by regulating carboxylesterase 2","volume":"193","author":"Takemoto","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.tem.2023.09.002_bb0190","article-title":"Insights into the role of nucleotide methylation in metabolic-associated fatty liver disease","volume":"14","author":"Zhang","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tem.2023.09.002_bb0195","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/s41575-019-0210-2","article-title":"Adaptive immunity: an emerging player in the progression of NAFLD","volume":"17","author":"Sutti","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.tem.2023.09.002_bb0200","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.ccell.2014.09.003","article-title":"Metabolic activation of intrahepatic CD8+ T cells and NKT cells causes nonalcoholic steatohepatitis and liver cancer via cross-talk with hepatocytes","volume":"26","author":"Wolf","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.tem.2023.09.002_bb0205","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aai7616","article-title":"Type I interferon responses drive intrahepatic T cells to promote metabolic syndrome","volume":"2","author":"Ghazarian","year":"2017","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.tem.2023.09.002_bb0210","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1136\/gutjnl-2011-301857","article-title":"NKT-associated hedgehog and osteopontin drive fibrogenesis in non-alcoholic fatty liver disease","volume":"61","author":"Syn","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.tem.2023.09.002_bb0215","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.jhep.2021.07.032","article-title":"Regulatory T-cell and neutrophil extracellular trap interaction contributes to carcinogenesis in non-alcoholic steatohepatitis","volume":"75","author":"Wang","year":"2021","journal-title":"J. Hepatol."},{"key":"10.1016\/j.tem.2023.09.002_bb0220","doi-asserted-by":"crossref","first-page":"C762","DOI":"10.1152\/ajpcell.00212.2019","article-title":"The N6-methyladenosine (m6A)-forming enzyme METTL3 facilitates M1 macrophage polarization through the methylation of STAT1 mRNA","volume":"317","author":"Liu","year":"2019","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.tem.2023.09.002_bb0225","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/nature23450","article-title":"m6A mRNA methylation controls T cell homeostasis by targeting the IL-7\/STAT5\/SOCS pathways","volume":"548","author":"Li","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.tem.2023.09.002_bb0230","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/cr.2018.7","article-title":"m6A mRNA methylation sustains Treg suppressive functions","volume":"28","author":"Tong","year":"2018","journal-title":"Cell Res."},{"key":"10.1016\/j.tem.2023.09.002_bb0235","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1038\/s41467-019-09903-6","article-title":"Mettl3-mediated mRNA m6A methylation promotes dendritic cell activation","volume":"10","author":"Wang","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tem.2023.09.002_bb0240","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-019-0916-x","article-title":"Anti-tumour immunity controlled through mRNA m6A methylation and YTHDF1 in dendritic cells","volume":"566","author":"Han","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.tem.2023.09.002_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107819","article-title":"Control of early B cell development by the RNA N6-methyladenosine methylation","volume":"31","author":"Zheng","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.tem.2023.09.002_bb0250","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s40104-022-00733-z","article-title":"Lipid metabolism and m6A RNA methylation are altered in lambs supplemented rumen-protected methionine and lysine in a low-protein diet","volume":"13","author":"Gebeyew","year":"2022","journal-title":"J. Anim. Sci. Biotechnol."},{"key":"10.1016\/j.tem.2023.09.002_bb0255","doi-asserted-by":"crossref","DOI":"10.1093\/jmcb\/mjac061","article-title":"Aberrant elevation of FTO levels promotes liver steatosis by decreasing the m6A methylation and increasing the stability of SREBF1 and ChREBP mRNAs","volume":"14","author":"Tang","year":"2023","journal-title":"J. Mol. Cell. Biol."},{"key":"10.1016\/j.tem.2023.09.002_bb0260","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.bbalip.2018.02.003","article-title":"FTO promotes SREBP1c maturation and enhances CIDEC transcription during lipid accumulation in HepG2 cells","volume":"1863","author":"Chen","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.tem.2023.09.002_bb0265","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/cbin.11490","article-title":"Fat mass and obesity-associated protein regulates lipogenesis via m6A modification in fatty acid synthase mRNA","volume":"45","author":"Sun","year":"2021","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.tem.2023.09.002_bb0270","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/s41420-022-01234-8","article-title":"LINC01468 drives NAFLD\u2013HCC progression through CUL4A-linked degradation of SHIP2","volume":"8","author":"Wang","year":"2022","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.tem.2023.09.002_bb0275","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ab.2019.05.005","article-title":"Role of identified RNA N6-methyladenosine methylation in liver","volume":"578","author":"Xu","year":"2019","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.tem.2023.09.002_bb0280","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1016\/j.ymthe.2022.02.021","article-title":"Dysregulated m6A modification promotes lipogenesis and development of non-alcoholic fatty liver disease and hepatocellular carcinoma","volume":"30","author":"Yang","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.tem.2023.09.002_bb0285","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1007\/s10620-012-2516-6","article-title":"Fat mass and obesity-associated gene enhances oxidative stress and lipogenesis in nonalcoholic fatty liver disease","volume":"58","author":"Guo","year":"2013","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.tem.2023.09.002_bb0290","first-page":"628","article-title":"Hepatic expression of FTO and fatty acid metabolic genes changes in response to lipopolysaccharide with alterations in m6A modification of relevant mRNAs in the chicken","volume":"57","author":"Zhang","year":"2016","journal-title":"Br. Poult. Sci."},{"key":"10.1016\/j.tem.2023.09.002_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2021.145285","article-title":"Triclosan-induced abnormal expression of miR-30b regulates FTO-mediated m6A methylation level to cause lipid metabolism disorder in zebrafish","volume":"770","author":"Sun","year":"2021","journal-title":"Sci. Total Environ."},{"key":"10.1016\/j.tem.2023.09.002_bb0300","doi-asserted-by":"crossref","first-page":"7213","DOI":"10.1038\/s41467-021-27539-3","article-title":"The methyltransferase METTL3 negatively regulates nonalcoholic steatohepatitis (NASH) progression","volume":"12","author":"Li","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tem.2023.09.002_bb0305","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.bbrc.2019.08.018","article-title":"METTL3 inhibits hepatic insulin sensitivity via N6-methyladenosine modification of Fasn mRNA and promoting fatty acid metabolism","volume":"518","author":"Xie","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.tem.2023.09.002_bb0310","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.gpb.2020.06.003","article-title":"m6A regulates liver metabolic disorders and hepatogenous diabetes","volume":"18","author":"Li","year":"2020","journal-title":"Genomics Proteomics Bioinforma."},{"key":"10.1016\/j.tem.2023.09.002_bb0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109968","article-title":"m6A mRNA methylation-directed myeloid cell activation controls progression of NAFLD and obesity","volume":"37","author":"Qin","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.tem.2023.09.002_bb0320","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.ymthe.2021.09.016","article-title":"METTL3\u2013m6A\u2013Rubicon axis inhibits autophagy in nonalcoholic fatty liver disease","volume":"30","author":"Peng","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.tem.2023.09.002_bb0325","article-title":"AS3MT facilitates NLRP3 inflammasome activation by m6A modification during arsenic-induced hepatic insulin resistance","author":"Qiu","year":"2022","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.tem.2023.09.002_bb0330","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s10020-023-00615-8","article-title":"RBM15 suppresses hepatic insulin sensitivity of offspring of gestational diabetes mellitus mice via m6A-mediated regulation of CLDN4","volume":"29","author":"Fang","year":"2023","journal-title":"Mol. Med."},{"key":"10.1016\/j.tem.2023.09.002_bb0335","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/hep.31220","article-title":"N6-methyladenosine reader protein YT521-B homology domain-containing 2 suppresses liver steatosis by regulation of mRNA stability of lipogenic genes","volume":"73","author":"Zhou","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.tem.2023.09.002_bb0340","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.jcmgh.2021.05.007","article-title":"METTL3\/METTL14 transactivation and m6A-dependent TGF-\u03b21 translation in activated Kupffer cells","volume":"12","author":"Feng","year":"2021","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.tem.2023.09.002_bb0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.envpol.2023.121887","article-title":"METTL3-mediated m6A mRNA modification was involved in cadmium-induced liver injury","volume":"331","author":"Li","year":"2023","journal-title":"Environ. Pollut."},{"key":"10.1016\/j.tem.2023.09.002_bb0350","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1136\/gutjnl-2013-305736","article-title":"The insulin-like growth factor 2 (IGF2) mRNA-binding protein p62\/IGF2BP2-2 as a promoter of NAFLD and HCC?","volume":"63","author":"Simon","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.tem.2023.09.002_bb0355","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3389\/fmed.2019.00179","article-title":"IGF2 mRNA binding protein 2 transgenic mice are more prone to develop a ductular reaction and to progress toward cirrhosis","volume":"6","author":"Czepukojc","year":"2019","journal-title":"Front. Med. (Lausanne)"},{"key":"10.1016\/j.tem.2023.09.002_bb0360","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.jhep.2010.08.034","article-title":"Overexpression of the IGF2-mRNA binding protein p62 in transgenic mice induces a steatotic phenotype","volume":"54","author":"Tybl","year":"2011","journal-title":"J. Hepatol."},{"key":"10.1016\/j.tem.2023.09.002_bb0365","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aau7116","article-title":"Identification of entacapone as a chemical inhibitor of FTO mediating metabolic regulation through FOXO1","volume":"11","author":"Peng","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.tem.2023.09.002_bb0370","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/nar\/gku1276","article-title":"Meclofenamic acid selectively inhibits FTO demethylation of m6A over ALKBH5","volume":"43","author":"Huang","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.tem.2023.09.002_bb0375","article-title":"Ling-gui-zhu-gan decoction alleviates hepatic steatosis through SOCS2 modification by N6-methyladenosine","volume":"127","author":"Dang","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.tem.2023.09.002_bb0380","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s13105-015-0420-1","article-title":"FTO-dependent function of N6-methyladenosine is involved in the hepatoprotective effects of betaine on adolescent mice","volume":"71","author":"Chen","year":"2015","journal-title":"J. Physiol. Biochem."},{"key":"10.1016\/j.tem.2023.09.002_bb0385","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/lipd.12023","article-title":"Curcumin attenuates lipopolysaccharide-induced hepatic lipid metabolism disorder by modification of m6A RNA methylation in piglets","volume":"53","author":"Lu","year":"2018","journal-title":"Lipids"},{"key":"10.1016\/j.tem.2023.09.002_bb0390","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.568006","article-title":"Resveratrol attenuates high-fat diet induced hepatic lipid homeostasis disorder and decreases m6A RNA methylation","volume":"11","author":"Wu","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.tem.2023.09.002_bb0395","article-title":"METTL3 drives NAFLD-related hepatocellular carcinoma and is a therapeutic target for boosting immunotherapy","volume":"4","author":"Pan","year":"2023","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.tem.2023.09.002_bb0400","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/s41574-021-00507-z","article-title":"Emerging therapeutic approaches for the treatment of NAFLD and type 2 diabetes mellitus","volume":"17","author":"Ferguson","year":"2021","journal-title":"Nat. Rev. Endocrinol."}],"container-title":["Trends in Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043276023001911?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043276023001911?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T20:45:29Z","timestamp":1760906729000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043276023001911"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":80,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S1043276023001911"],"URL":"https:\/\/doi.org\/10.1016\/j.tem.2023.09.002","relation":{},"ISSN":["1043-2760"],"issn-type":[{"value":"1043-2760","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"N6-methyladenosine RNA modification in nonalcoholic fatty liver disease","name":"articletitle","label":"Article Title"},{"value":"Trends in Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tem.2023.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}